Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders.
ACS pharmacology & translational science – March 14, 2025
Source: PubMed
Summary
Research suggests that psychedelics like LSD and psilocybin may enhance social behaviors in individuals with Autism Spectrum Disorders. By promoting empathy and emotional connection, these substances could offer new avenues for improving social interactions and communication, potentially transforming lives positively.
Abstract
Autism Spectrum Disorders (ASD) are complex neurodevelopmental conditions characterized by deficits in social interaction, communication, and repetitive behaviors. This viewpoint explores the potential mechanisms through which psychedelics such as lysergic acid diethylamide (LSD), psilocybin, and 3,4-methylenedioxymethamphetamine (MDMA) may positively influence pro-social behaviors, focusing on their implications for individuals with ASD.